03:37 PM EDT, 07/21/2025 (MT Newswires) -- Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.4%.

The iShares Biotechnology ETF (IBB) eased 0.2%.

In corporate news, Amgen ( AMGN ) is expected to report a slight Q2 beat as key product script trends remain solid, UBS said. UBS raised its price target on the stock to $326 from $315 and kept its neutral rating. Amgen ( AMGN ) shares rose 0.4%.